Global Cord Blood (NYSE:CO) Now Covered by StockNews.com

StockNews.com assumed coverage on shares of Global Cord Blood (NYSE:CO) in a research report released on Friday. The firm issued a strong-buy rating on the medical research company’s stock.

Global Cord Blood Stock Down 19.1 %

NYSE:CO opened at $0.83 on Friday. The company has a market cap of $100.28 million, a P/E ratio of 1.29 and a beta of 0.16. Global Cord Blood has a twelve month low of $2.03 and a twelve month high of $5.50. The business has a 50 day moving average price of $1.00 and a two-hundred day moving average price of $1.28.

About Global Cord Blood

Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The firm preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants.